Medication Subsidy (PBAC), Medications and Treatments, Disease Modifying Therapy, DMT, Pharmaceutical Benefits Advisory Committee, PBAC
Submission of a new form of natalizumab (Tysabri®) for RRMS to PBAC meeting March 20232023-01-232024-09-02https://msra.org.au/wp-content/uploads/2016/03/MSRA-logo.jpgMS Australiahttps://www.msaustralia.org.au/wp-content/uploads/tysabri-website-image.jpg200px200px
